
ECP, commonly known as the “morning-after pill,” is an oral emergency contraceptive intended to prevent pregnancy following unprotected intercourse or contraceptive failure. Most ECP formulations utilize Levonorgestrel, a synthetic progestogen, to inhibit or delay ovulation.
Active Ingredient: Levonorgestrel (typically 1.5 mg in a single dose).
Pharmacologic Class: Progestin; Emergency Contraceptive.
Primary Indication: Prevention of pregnancy within 72 hours (3 days) of unprotected sexual contact.
Mechanism of Action: Primarily acts by suppressing the surge of Luteinizing Hormone (LH), thereby delaying or preventing follicular rupture (ovulation).
Efficacy: Effectiveness is highest when administered as soon as possible after exposure; it does not terminate an existing pregnancy.
Professional Note: ECP is not intended for routine use as a primary method of contraception and does not provide protection against sexually transmitted infections (STIs).
This is for informational purposes only. For medical advice or diagnosis, consult a professional.
You must be logged in to post a review.
Reviews
There are no reviews yet.